Clin2
NCT07733817Likely a fitNot yet recruiting

Probiotics to prevent nerve damage from colon cancer chemo

Colon AdenocarcinomaNeuropathic Pain

Part of Brain & nervous system, Cancer, Digestive system, Pain clinical trials.

This trial tests whether taking probiotics can reduce nerve damage (peripheral neuropathy) caused by oxaliplatin chemotherapy in people with stage III colon cancer. If you are starting chemo soon, this study may help protect your nerves.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
130 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older with stage III colon cancer that was fully removed by surgery.
  • You are about to start chemotherapy with oxaliplatin (FOLFOX or XELOX).
  • You must be in good overall health (able to do daily activities with little or no help).
  • You cannot have any nerve damage or take medicines for nerve pain now.
  • You haven't taken probiotics or antibiotics in the last month.
  • You agree to give blood and stool samples for research.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05850130Recruiting
Acupuncture to treat nerve pain from oxaliplatin chemotherapy

This study tests whether acupuncture can reduce nerve pain caused by oxaliplatin chemotherapy in people with gastrointestinal cancers. It may help lessen symptoms like tingling, numbness, or burning that affect hands or feet.

Créteil
NCT06856447Recruiting· Phase 1
Coenzyme Q10 to prevent nerve damage from chemotherapy

This trial tests whether taking coenzyme Q10 (a natural substance) can help prevent nerve damage caused by the chemotherapy drug oxaliplatin in people with stage III colorectal cancer. If successful, it could reduce pain, numbness, or tingling during treatment.

Cairo
NCT06722950Not yet recruiting· Phase 2
AC591 to prevent nerve damage from oxaliplatin chemo

This trial tests a drug called AC591 to see if it can prevent nerve damage (tingling, numbness, pain) caused by oxaliplatin, a common chemo drug for colorectal cancer. It is for people starting CAPEOX chemo after colon cancer surgery.

NCT07167446Recruiting· Early Phase 1
CBD to prevent nerve damage from oxaliplatin in colorectal cancer

This trial tests if cannabidiol (CBD) can prevent nerve damage (neuropathy) caused by the chemotherapy drug oxaliplatin. If you have colorectal cancer that has spread or cannot be removed by surgery and you are about to start oxaliplatin, you may be able to join.

Philadelphia, Pennsylvania
NCT07504198Not yet recruiting· Phase 2/Phase 3
Memantine and rosuvastatin for nerve protection during chemo

This trial tests whether two common medications, memantine and rosuvastatin, can protect nerves during colorectal cancer treatment. If you are about to start chemotherapy with FOLFOX or XELOX, this study may help reduce nerve damage.

Tanta
NCT05404230Recruiting
Preventing nerve damage from oxaliplatin in the hands and feet

This study looks at ways to prevent numbness or nerve pain in the hands and feet that can happen from oxaliplatin treatment. It includes people with colon or rectal cancer who will be getting standard chemotherapy with capecitabine plus oxaliplatin.

Aalborg

Hear when a new Neuropathic Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.